Chijan Zuo
Vice President of R&D CureMed Biopharma
Ph.D. of The University of Freiburg (Germany), Chijian has 10 years’ experience in pharmaceutical industry. Their focus is on circRNA based therapeutics development in the past 6 years.
Seminars
Tuesday 21st July 2026
CircRNA-Based Potential Therapeutics for Tumor Therapy & Autoimmune Diseases
2:30 pm
- Clean-PIE circRNA platform of CureMed
- cmRNA1210: CircRNA based IL-12 for solid tumor
- CircRNA based in vivo TCE/CAR-T
